Cargando…
Follow-up of Metal-on-Metal Hip Replacements at a Large District Hospital and the Implementation of Medicines and Healthcare Products Regulatory Agency Guidelines: A Review of 297 Patients
BACKGROUND: Medicines and Healthcare products Regulatory Agency (MHRA) guidance for patients with metal-on-metal (MoM) hip replacements was provided in 2012 and updated in 2017 to assist in the early detection of soft-tissue reactions due to metal wear debris. A large number of MoM hip replacements...
Autores principales: | Hughes, Luke, Chamberlain, Kathryn, Robinson, Heather, Sloan, Andrew, Choudry, Qaisar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Orthopaedic Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867927/ https://www.ncbi.nlm.nih.gov/pubmed/31788162 http://dx.doi.org/10.4055/cios.2019.11.4.403 |
Ejemplares similares
-
Haemorrhagic Pseudotumour Following Metal-on-Metal Hip Replacement
por: Filer, Joshua L, et al.
Publicado: (2021) -
Imaging Metal-on-Metal Hip Replacements: the Norwich Experience
por: Thomas, Marianna S., et al.
Publicado: (2013) -
How much does a Medical and Healthcare Products Regulatory Agency medical device alert for metal-on-metal hip arthroplasty patients really cost?
por: Nandra, Rajpal S, et al.
Publicado: (2021) -
Risk of cancer with metal-on-metal hip replacements: population based study
por: Mäkelä, Keijo T, et al.
Publicado: (2012) -
Pseudotumor in Large Diameter Head Metal-on-metal Total Hip Replacement
por: Loures, Elmano de Araújo, et al.
Publicado: (2019)